News
TipRanks on MSN2d
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
Imunon, Inc. (($IMNN)) announced an update on their ongoing clinical study. Imunon, Inc. is conducting a Phase 3 clinical trial titled A ...
Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.
DelveInsight's,“ Fallopian Tube Cancer Pipeline Insight 2025 ” report provides comprehensive insights about 70+ Fallopian ...
Explore Sonnet BioTherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SONN.
Explore Portage Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRTG.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback